DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on June 18, 2007; DOI: 10.1124/dmd.107.015388


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.015388v1
35/9/1664    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Godin, S. J
Right arrow Articles by Ross, M. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godin, S. J
Right arrow Articles by Ross, M. K


Received for publication February 28, 2007.
Revised June 12, 2007.
Accepted for publication June 13, 2007.

Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate

Stephen J Godin 1, J. Allen Crow 2, Edward J Scollon 3, Michael F Hughes 3, Michael J DeVito 3*, Matthew K Ross 2

1 University of North Carolina at Chapel Hill 2 Mississippi State University 3 USEPA

* Address correspondence to: E-mail: devito.mike{at}epa.gov

Abstract

The metabolism of deltamethrin and esfenvalerate by rat and human liver microsomes differ with respect to the biotransformation pathway (oxidation versus hydrolysis) responsible for their clearance. This study aims to further explore the species differences in the metabolism of these chemicals. Using a parent depletion approach, rat and human CYPs were screened for their ability to eliminate deltamethrin or esfenvalerate during in vitro incubations. Rat CYP isoforms 1A1, 2C6, 2C11, 3A2 and human CYP isoforms 2C8, 2C19,and 3A5 were capable of metabolizing either pyrethroid. Human CYP2C9 metabolized esfenvalerate but not deltamethrin. Rat and human CYPs that metabolize esfenvalerate and deltamethrin do so with similar kinetics. In addition to the liver, a potential site of metabolic elimination of pyrethroids is the blood via serum carboxylesterase (CEs) hydrolysis. The serum of rats, but not humans, contains significant quantities of CEs. Deltamethrin and esfenvalerate were metabolized effectively by rat serum and a purified rat serum CE. In contrast, neither pyrethroid was metabolized by human serum or purified human serum esterases (acetylcholinesterase and butyrylcholinesterase). These studies suggest that the difference in rates of oxidative metabolism of pyrethroids by rat and human hepatic microsomes are dependent on the expression levels of individual CYP isoforms rather than their specific activity. Furthermore, these studies show that the metabolic elimination of deltamethrin and esfenvalerate in blood may be important to their disposition in the rat but not in the human.


Key words: carboxylesterases, cytochrome P450, cytochrome P450 isoforms, environmental toxicology, human CYP enzymes, insecticides


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
E. J. Scollon, J. M. Starr, S. J. Godin, M. J. DeVito, and M. F. Hughes
In Vitro Metabolism of Pyrethroid Pesticides by Rat and Human Hepatic Microsomes and Cytochrome P450 Isoforms
Drug Metab. Dispos., January 1, 2009; 37(1): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. S. Lee, W. O. Ward, D. C. Wolf, J. W. Allen, C. Mills, M. J. DeVito, and J. C. Corton
Coordinated Changes in Xenobiotic Metabolizing Enzyme Gene Expression in Aging Male Rats
Toxicol. Sci., November 1, 2008; 106(1): 263 - 283.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.